A detailed history of Cwm, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Cwm, LLC holds 12,814 shares of ARDX stock, worth $66,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,814
Previous 2,993 328.13%
Holding current value
$66,248
Previous $22,000 300.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$5.28 - $7.57 $51,854 - $74,344
9,821 Added 328.13%
12,814 $88,000
Q2 2024

Jul 09, 2024

BUY
$5.89 - $9.31 $17,569 - $27,771
2,983 Added 29830.0%
2,993 $22,000
Q1 2024

Apr 05, 2024

BUY
$6.05 - $9.74 $60 - $97
10 New
10 $0
Q2 2023

Aug 03, 2023

BUY
$3.23 - $4.95 $406 - $623
126 New
126 $0
Q2 2022

Jul 28, 2022

BUY
$0.51 - $1.17 $204 - $468
400 New
400 $0

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $799M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.